465 related articles for article (PubMed ID: 15119909)
1. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
Weisler RH; Kalali AH; Ketter TA;
J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
[TBL] [Abstract][Full Text] [Related]
2. Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
Weisler RH; Keck PE; Swann AC; Cutler AJ; Ketter TA; Kalali AH;
J Clin Psychiatry; 2005 Mar; 66(3):323-30. PubMed ID: 15766298
[TBL] [Abstract][Full Text] [Related]
3. A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes.
Ketter TA; Kalali AH; Weisler RH;
J Clin Psychiatry; 2004 May; 65(5):668-73. PubMed ID: 15163253
[TBL] [Abstract][Full Text] [Related]
4. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Ketter TA; Keck PE; Swann A; Kalali A;
CNS Drugs; 2006; 20(3):219-31. PubMed ID: 16529527
[TBL] [Abstract][Full Text] [Related]
5. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
Ginsberg LD
Ann Clin Psychiatry; 2006; 18 Suppl 1():9-14. PubMed ID: 16754406
[TBL] [Abstract][Full Text] [Related]
6. Switching from other agents to extended-release carbamazepine in acute mania.
El-Mallakh RS; Ketter TA; Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Keck P; Swann AC; Kalali AH
Psychopharmacol Bull; 2008; 41(1):52-8. PubMed ID: 18362871
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
[TBL] [Abstract][Full Text] [Related]
8. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
Vasudev K; Goswami U; Kohli K
Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972
[TBL] [Abstract][Full Text] [Related]
10. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
11. A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder.
Joshi G; Wozniak J; Mick E; Doyle R; Hammerness P; Georgiopoulos A; Kotarski M; Aleardi M; Williams C; Walls S; Biederman J
J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):7-14. PubMed ID: 20166791
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I Disorder.
Weisler RH; Kalali AH; Cutler AJ; Gazda TD; Ginsberg L
Psychiatry (Edgmont); 2008 Mar; 5(3):35-48. PubMed ID: 22778707
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive herbal medicine with carbamazepine for bipolar disorders: A double-blind, randomized, placebo-controlled study.
Zhang ZJ; Kang WH; Tan QR; Li Q; Gao CG; Zhang FG; Wang HH; Ma XC; Chen C; Wang W; Guo L; Zhang YH; Yang XB; Yang GD
J Psychiatr Res; 2007; 41(3-4):360-9. PubMed ID: 16081106
[TBL] [Abstract][Full Text] [Related]
15. Extended-release carbamazepine for acute bipolar mania: a review.
Owen RT
Drugs Today (Barc); 2006 May; 42(5):283-9. PubMed ID: 16801991
[TBL] [Abstract][Full Text] [Related]
16. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.
Calabrese JR; Bowden CL; Sachs GS; Ascher JA; Monaghan E; Rudd GD
J Clin Psychiatry; 1999 Feb; 60(2):79-88. PubMed ID: 10084633
[TBL] [Abstract][Full Text] [Related]
17. Evaluating response to mood stabilizers in patients with mixed depression: A study of agreement between three different mania rating scales and a depression rating scale.
Shansis FM; Reche M; Capp E
J Affect Disord; 2016 Jun; 197():1-7. PubMed ID: 26950019
[TBL] [Abstract][Full Text] [Related]
18. Adverse event load in bipolar participants receiving either carbamazepine immediate-release or extended-release capsules: a blinded, randomized study.
El-Mallakh RS; Salem MR; Chopra AS; Mickus GJ; Penagaluri P
Int Clin Psychopharmacol; 2009 May; 24(3):145-9. PubMed ID: 19367153
[TBL] [Abstract][Full Text] [Related]
19. Predictors of response to carbamazepine extended-release capsules treatment in bipolar disorder.
Ginsberg LD
Ann Clin Psychiatry; 2006; 18 Suppl 1():23-6. PubMed ID: 16754409
[TBL] [Abstract][Full Text] [Related]
20. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
Zhang ZJ; Kang WH; Li Q; Tan QR
J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
